Who We Are

We’re Delivering the Promise of Healthier Lives.

Our Origin


CURE Pharmaceutical was born when one of our founders was on a medical mission trip in Africa where he realized a pressing need for a better way to deliver drug actives.

Putting our Planet First

At CURE Pharmaceutical, we strive to improve the company’s eco-friendliness by leveraging the benefits of our oral thin film technology, among other initiatives.

Social Responsibility

Supporting People and our Community

We are a people-focused, purpose-driven company with a commitment to global health, accessibility to food and medicines, and safety and freedom for all.

Our corporate responsibility efforts focus on both local and global efforts in service of these goals.


Foundation with a Purpose

Widening Global Access to Medicine Through Innovative Solutions

The problem is that emerging countries typically do not have easy access to clean drinking water and, oftentimes,

unsanitized water is the cause of the diseases the prescription aims to treat. Parents, desperate to keep their children healthy and alive, were giving their children soda or juice to take the medicine. Unknowingly, parents were making their children’s medicine ineffective and, as a result, many children were dying of completely curable diseases. CURE’s founders knew there had to be a better way to save these young lives, so they set out to develop a drug delivery technology that required no water for intake. The result is CURE’s flagship innovative oral thin film technology. Storage and shipping costs are also important in emerging countries where they have limited funds and storage space. CURE’s oral thin films are more cost-effective and compact to ship than pills and can be easily stored in rolls.

Proven Expertise.
Purpose-driven Leadership

CURE’s founders and leaders are industry experts, shown by their years of experience

Robert Davidson

Robert Davidson

Founder and CEO

Founder and CEO

CURE Founder and CEO Robert Davidson has extensive experience in pharmaceutical and nutraceutical wellness product development, having patented and sold billions in consumer products. Prior to CURE, Mr. Davidson served as President and Chief Executive Officer of InnoZen, Inc, where he developed and patented a best-selling wellness product Zicam. Mentioned in the Washington Post, like many other scientific entrepreneurs, Davidson thought zinc might be a promising treatment for the common cold. Turns out he was right and the product has sold billions over the years. Beyond his time at InnoZen, Inc. he has served as Chief Executive Officer of Gel Tech LLC, Chief Executive Officer of Bio Delivery Technologies Inc., and has served on multiple corporate boards.  Mr. Davidson was responsible for the development of several drug delivery technologies and commercial brand extensions. He has worked with brands such as Chloraseptic™, Suppress™, as well as Pediastrip™, a private label electrolyte oral thin film sold in major drug store chains.

Robert Davidson

Robert Davidson

Founder and CEO


Our Sustainability Efforts  

Changing Healthcare Without Hurting the Planet 

CURE is considered a small waste generator as regulated by the EPA and local municipalities. CURE technology is aqueous-based and waste byproducts are neutral, thus reducing hazardous waste streams.

At CURE Pharmaceutical, we strive to improve the company’s eco-friendliness by leveraging the benefits of our oral thin film technology. We work to reduce waste and resource consumption by:

  •  Lowering energy consumption
  • Reducing our water use
  • Lowering volume waste streams
  • Streamlining production with concurrent filling and finishing
  • Establishing critical processing controls that are highly leveraged between products
  • Eliminating costly and unnecessary sterilization equipment
  • Reducing processing steps that can introduce third-party containers and closures
  • Reducing cleaning validation
  • Improving fast product transfers

The CURE process capacity is flexible and is easily tailored to a wide range of products and dosages. We designed our process equipment to use a semi-continuous curing and converting process, so we can run longer for larger lots, as opposed to the batch process with the equipment. Because of modularity, our process is very scalable if mega lot sizes are required and greatly reduces energy consumption

CURE’s development and manufacturing footprint is extremely compact when compared to traditional equipment pharma production facilities. This results in less space requirements and fewer process steps than traditional pharma manufacturing.

One of the ways CURE differentiates its position in the drug delivery and dietary supplement space is by reducing scrap production even further while also reducing the amount of materials, which is a focus for regulatory body mandates.

Our primary package containing product is engineered for single-use dispensing and can be densely stacked for highly efficient transport into distribution markets, which reduces fuel emissions.

Shipping conditions are ambient, thus avoiding complicated and environmentally unfriendly ‘cool-chain’ insulated shippers.

CURE is investing in its IT solutions in an effort to go paperless with financial, quality and laboratory systems. We also have added local automation to major process equipment to reduce operator interventions, thus reducing operator errors and improving process/product reliability. This reduces our carbon footprint with less paper and maximizes the potential with each CURE staff member.

Our Commitment

Corporate Social Responsibility

Working to End Food Inequality with Food Share Ventura County

In 2018, an estimated 1 in 9 Americans were food insecure, equating to over 37 million Americans, including more than 11 million children. Now, the number of people in the United States experiencing food insecurity is at historic levels.

CURE’s team members volunteer on a regular basis to help with food planting, harvesting, and packing.

To learn more about Food Share and Feeding America, visit their website at:

A Global Healthcare Awareness Initiative with United Smart Cities

CURE was founded on the principles of affordability and global accessibility of medications. We are driven to finding healthcare solutions for people of all ages and demographics and partnered with United Smart Cities in service to this cause. Our mutual goal is to invigorate health and elevate living standards through education and sustainable new technologies.

Recognizing escalating healthcare costs, CURE and United Smart Cities will seek to promote education and innovation in delivering cost-effective and sustainable treatments to the world’s population.

The United Smart Cities program is a global multi-stakeholder initiative, established by the Organization for International Economic Relations (OiER) in cooperation with the United Nations Economic Commission for Europe (UNECE) and other international organizations, cities, industry and finance sector.

The aim of the United Smart Cities program is to evaluate cities’ performances and set priorities for action, develop analysis of cities (city profiles), support strategies in terms of urban planning and priorities (action plan), project development, finance options, and investors’ engagement in cooperation with urban experts and the private sector.

Committed to the permanent eradication of child sex trafficking with Operation Underground Railroads

CURE is a corporate sponsor of Operation Underground Railroad (OUR). Founded in December 2013, OUR exists to save children from sex trafficking.

O.U.R.’s Ops Team consists of former CIA, past and current law enforcement, and highly skilled operatives that lead coordinated identification and extraction efforts. These operations are always in conjunction with law enforcement throughout the world.

To learn more about how OUR works to rescue and rehabilitate with law enforcement and aftercare partners, visit their website at:

We Support Time Off to Vote

At CURE, we give our employees a paid day off so they can participate in the election process that is essential to a democratic society. We believe that employees shouldn’t have to choose between earning a paycheck and voting.
Time To Vote is a nonpartisan movement, led by the business community, to contribute to the culture shift needed to increase voter participation in our country’s elections.
CURE is part of a group of 600+ companies that want to contribute to the culture shift needed to increase voter participation in our country’s elections.

To learn more about how Time To Vote, visit their website at:

Our Company by the Numbers


Certifications including cGMP, ISO, and more

Years in Business


25,000 sq. ft. of Manufacturing

Our state-of-the-art facility is FDA and cGMP certified. 

Our facility is located at 1620 Beacon Place, Oxnard, CA 93033 and is approximately 25,000 square feet.

It has NSF International, cGMP certification for the manufacturing of dietary supplements and is FDA-registered, enabling us to partner with pharmaceutical and wellness companies worldwide for private and white-labeled production. While we currently manufacture nutraceutical products in our state-of-the-art cGMP oral dissolving film manufacturing facility, we are undertaking steps to manufacture pharmaceutical products for commercial use. We currently sell white-labeled and private-labeled wellness products which we produce in our facility. It is registered with the Drug Enforcement Agency to manufacture Schedule I controlled substances.